Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2022 (1)
  • 2021 (1)
  • 2019 (1)

Subject

  • Drug Trafficking (103)
  • Prescription Drugs (75)
  • Pharmaceuticals/Pharmacists/Physicians (47)
  • Diversion Division (37)
  • OCDETF/Task Force (34)
  • Fake Pills (29)
  • Synthetic drugs (25)
  • Guns/Weapons (24)
  • Seizures (Drugs/Property) (15)
  • Overdose (14)
  • Task Forces/Task Force Officers (12)
  • Arrests/Convictions - Major (11)
  • Guilty Plea (11)
  • Dark Web- Internet Trafficking (6)
  • Major Law Enforcement Operation (6)
  • Take Back Day (5)
  • Asset Forfeiture (3)
  • Gangs (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Outreach/Drug Prevention (2)
  • Press Conferences (2)
  • HIDTA (1)
  • Money Laundering (1)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Congressional Affairs (1)

Drug Name

  • Fentanyl (11)
  • Methamphetamine (5)
  • Synthetic Opioids (5)
  • Opioids (3)
  • Heroin (2)
  • Benzodiazepines (1)
  • Cocaine (1)
  • Hydromorphone (1)
  • Morphine (1)
  • Oxycodone (3)

Field Division

  • New York (1)
  • Sede (1)
  • Washington, DC (1)
Clear All Results
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Enero 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
Enero 27, 2022
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

Septiembre 27, 2021
NEW YORK – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
Septiembre 27, 2021
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

Febrero 26, 2019
WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
Febrero 26, 2019
Showing 1 - 3 of 3 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster